AAAAAA

   
Results: 1-12 |
Results: 12
The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury
Authors: Kupina, NC Nath, R Bernath, EE Inoue, J Mitsuyoshi, A Yuen, PW Wang, KKW Hall, ED
Citation: Nc. Kupina et al., The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury, J NEUROTRAU, 18(11), 2001, pp. 1229-1240
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Authors: Albers, GW Bogousslavsky, J Bozik, MA Brass, LM Broderick, JP Fisher, M Goldstein, LB Salazar-Grueso, E Akitsuki, S Aranko, K Ashwood, T Atkinson, RP Bell, RD Brott, TG Cady, WJ Caplan, LR Coggins, S Cramer, S Cyrus, P Dayno, J Easton, JD Elliott, PJ Finklestein, SP Furlan, AJ Gamzu, E Glasky, MS Gordon, K Gorelick, PB Greenwood, DT Grotta, JC Gunn, K Hachinski, V Hacke, W Hall, ED Hsu, CY Humphreys, DM Ishikawa, H Jacobs, AJ Kaste, M Koroshetz, WJ Krams, M Lauritano, AA Leclerc, J Lees, KR Lesko, L Levine, SR Levy, DE Li, FH Lyden, PD Masayasu, H McDermott, J Meibach, RC Meya, U Miyairi, K Niidome, T Oeda, J Poole, RM Ron, ES Sacco, RL Saltarelli, MD Shimizu, K Shook, BJ Soehngen, M Soehngen, W Stamler, DA Styren, SD Teal, PA Tilley, BC Traystman, RJ Walker, MD Wallin, BA Warach, S Ward, DP Wessel, TC Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats
Authors: Roof, RL Schielke, GP Ren, XD Hall, ED
Citation: Rl. Roof et al., A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats, STROKE, 32(11), 2001, pp. 2648-2657
Gender differences in acute CNS trauma and stroke: Neuroprotective effectsof estrogen and progesterone
Authors: Roof, RL Hall, ED
Citation: Rl. Roof et Ed. Hall, Gender differences in acute CNS trauma and stroke: Neuroprotective effectsof estrogen and progesterone, J NEUROTRAU, 17(5), 2000, pp. 367-388
Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats
Authors: Roof, RL Hall, ED
Citation: Rl. Roof et Ed. Hall, Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats, J NEUROTRAU, 17(12), 2000, pp. 1155-1169
4-hydroxy-2,2,6,6-tetramethylpiperidine (Tempol) inhibits peroxynitrite-mediated phenol nitration
Authors: Carroll, RT Galatsis, P Borosky, S Kopec, KK Kumar, V Althaus, JS Hall, ED
Citation: Rt. Carroll et al., 4-hydroxy-2,2,6,6-tetramethylpiperidine (Tempol) inhibits peroxynitrite-mediated phenol nitration, CHEM RES T, 13(4), 2000, pp. 294-300
LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels
Authors: Althaus, JS Schmidt, KR Fountain, ST Tseng, MT Carroll, RT Galatsis, P Hall, ED
Citation: Js. Althaus et al., LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels, FREE RAD B, 29(11), 2000, pp. 1085-1095
Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats - Comment
Authors: Hall, ED
Citation: Ed. Hall, Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats - Comment, STROKE, 31(1), 2000, pp. 160-160
Recommendations for standards regarding preclinical neuroprotective and restorative drug development
Authors: Feinklestein, SP Fisher, M Furland, AJ Goldstein, LB Gorelick, PB Kaste, M Lees, KR Traystman, RJ Albers, GW Anwer, UE Ashwood, T Barone, FC Basta, SL Bogousslavsky, J Buchan, AM Cady, WJ Chan, PH Clemens, JA Cox, BF Craddock, RE Cramer, SC del Zoppo, GJ Dielrich, WD Elliott, P Faden, AI Feuerstein, GZ Ginsberg, MD Gold, M Greene, WL Hall, ED Hsu, CY Hunter, AJ Lai, M Lesko, LM Levy, DE Li, FH Locke, KW Lodge, D Lowe, D Marcoux, FW McCulloch, J McDermott, J Meibach, R Messersmith, EK Moseley, M Moskowitz, MA Mueller, AL Munro, F Nudo, RJ Oeda, J Ohlstein, EH Parsons, A Patmore, L Poole, RM Pschorn, U Pulsinelli, WA Sacco, RL Saeki, S Salazar-Grueso, E Sandage, BW Schallert, T Schielke, GP Sharkey, J Sotak, CH Steiger, B Storall, S Takahashi, Y Tumas, D Van Bruggen, N Versavel, M Vornov, J Walker, MD Wallin, B Wang, J Warach, S Wells, DS Witcher, JA
Citation: Sp. Feinklestein et al., Recommendations for standards regarding preclinical neuroprotective and restorative drug development, STROKE, 30(12), 1999, pp. 2752-2758
Magnetic resonance, hyperthermia and oncology
Authors: Jayasundar, R Hall, ED Bleehen, NM
Citation: R. Jayasundar et al., Magnetic resonance, hyperthermia and oncology, CURRENT SCI, 76(6), 1999, pp. 794-799
Free radicals in stroke
Authors: Hall, ED
Citation: Ed. Hall, Free radicals in stroke, STROKE THERAPY, 1999, pp. 245-270
Mutant Cu,Zn superoxide dismutase in motor neuron disease
Authors: Gurney, ME Liu, RG Althaus, JS Hall, ED Becker, DA
Citation: Me. Gurney et al., Mutant Cu,Zn superoxide dismutase in motor neuron disease, AGE, 21(2), 1998, pp. 85-89
Risultati: 1-12 |